{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T02:39:16Z","timestamp":1794883156936,"version":"4.9.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","gynecologiconcology-online.net","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.ygyno.2021.02.017","type":"journal-article","created":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T18:49:52Z","timestamp":1614970192000},"page":"347-352","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["Sentinel lymph node (SLN) isolated tumor cells (ITCs) in otherwise stage I\/II endometrioid endometrial cancer: To treat or not to treat?"],"prefix":"10.1016","volume":"161","author":[{"given":"F.J.","family":"Backes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.S.","family":"Felix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Plante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Gr\u00e9goire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.A.","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.C.","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"E.J.","family":"Tanner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.I.","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.T.","family":"Soliman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.W.","family":"Holloway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.R.","family":"Abu-Rustum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"M.M.","family":"Leitao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2021.02.017_bb0005","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ygyno.2019.03.252","article-title":"Prospective clinical trial of robotic sentinel lymph node assessment with isosulfane blue (ISB) and indocyanine green (ICG) in endometrial cancer and the impact of ultrastaging (NCT01818739)","volume":"153","author":"Backes","year":"2019","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2021.02.017_bb0010","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.ygyno.2012.02.021","article-title":"The importance of applying a sentinel lymph node mapping algorithm in endometrial cancer staging: beyond removal of blue nodes","volume":"125","author":"Barlin","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2021.02.017_bb0015","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.ygyno.2017.09.030","article-title":"Comparison of a sentinel lymph node mapping algorithm and comprehensive lymphadenectomy in the detection of stage IIIC endometrial carcinoma at higher risk for nodal disease","volume":"147","author":"Ducie","year":"2017","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2021.02.017_bb0020","first-page":"206","article-title":"Sentinel lymph node mapping with staging lymphadenectomy for patients with endometrial cancer increases the detection of metastasis","volume":"141","author":"Holloway","year":"2016","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2021.02.017_bb0025","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ygyno.2017.05.024","article-title":"Isolated tumor cells identified by sentinel lymph node mapping in endometrial cancer: does adjuvant treatment matter?","volume":"146","author":"Plante","year":"2017","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2021.02.017_bb0030","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ygyno.2018.08.022","article-title":"Multicenter study comparing oncologic outcomes between two nodal assessment methods in patients with deeply invasive endometrioid endometrial carcinoma: a sentinel lymph node algorithm versus a comprehensive pelvic and paraaortic lymphadenectomy","volume":"151","author":"Schlappe","year":"2018","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2021.02.017_bb0035","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.ygyno.2017.05.016","article-title":"A prospective validation study of sentinel lymph node mapping for high-risk endometrial cancer","volume":"146","author":"Soliman","year":"2017","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2021.02.017_bb0040","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.ygyno.2017.10.020","article-title":"Use of a novel sentinel lymph node mapping algorithm reduces the need for pelvic lymphadenectomy in low-grade endometrial cancer","volume":"147","author":"Tanner","year":"2017","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2021.02.017_bb0045","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1136\/ijgc-2019-000672","article-title":"Sentinel lymph node biopsy for robotic-assisted endometrial cancer staging: further improvement of perioperative outcomes","volume":"30","author":"Casarin","year":"2020","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2021.02.017_bb0050","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S1470-2045(17)30068-2","article-title":"A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study","volume":"18","author":"Rossi","year":"2017","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ygyno.2021.02.017_bb0060","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1245\/s10434-015-5040-z","article-title":"Low-volume lymph node metastasis discovered during sentinel lymph node mapping for endometrial carcinoma","volume":"23","author":"St Clair","year":"2016","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.ygyno.2021.02.017_bb0065","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ygyno.2015.04.008","article-title":"Predictors of non-sentinel lymph node (non-SLN) metastasis in patients with sentinel lymph node (SLN) metastasis in endometrial cancer","volume":"138","author":"Touhami","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2021.02.017_bb0070","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.ygyno.2014.03.019","article-title":"Impact of sentinel lymph node biopsy on the therapeutic management of early-stage endometrial cancer: results of a retrospective multicenter study","volume":"133","author":"Raimond","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2021.02.017_bb0075","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S1470-2045(18)30079-2","article-title":"Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial","volume":"19","author":"de Boer","year":"2018","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ygyno.2021.02.017_bb0080","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1056\/NEJMoa1813181","article-title":"Adjuvant chemotherapy plus radiation for locally advanced endometrial cancer","volume":"380","author":"Matei","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2021.02.017_bb0085","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2019.30.e35","article-title":"Sentinel lymph node mapping in endometrial and cervical cancer: a survey of practices and attitudes in gynecologic oncologists","volume":"30","author":"Chambers","year":"2019","journal-title":"J. Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2021.02.017_bb0090","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1006\/gyno.2000.6067","article-title":"Occult lymph node metastases detected by cytokeratin immunohistochemistry predict recurrence in node-negative endometrial cancer","volume":"80","author":"Yabushita","year":"2001","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2021.02.017_bb0095","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.ygyno.2012.08.026","article-title":"Ultrastaging of Para-aortic lymph nodes in stage IIIC1 endometrial cancer: a preliminary report","volume":"127","author":"Todo","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2021.02.017_bb0100","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9061999","article-title":"Low-volume nodal metastasis in endometrial Cancer: risk factors and prognostic significance","volume":"9","author":"Garcia Pineda","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.ygyno.2021.02.017_bb0105","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ygyno.2017.02.005","article-title":"Sensitivity and negative predictive value for sentinel lymph node biopsy in women with early-stage cervical cancer","volume":"145","author":"Salvo","year":"2017","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2021.02.017_bb0110","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ygyno.2019.04.654","article-title":"Sentinel lymph nodes (SLN) in endometrial cancer: the relationship between primary tumor histology, SLN metastasis size, and non-sentinel node metastasis","volume":"154","author":"Kennard","year":"2019","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2021.02.017_bb0115","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ygyno.2011.11.037","article-title":"Prognostic significance of low volume sentinel lymph node disease in early-stage cervical cancer","volume":"124","author":"Cibula","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2021.02.017_bb0120","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1001\/jama.2011.1034","article-title":"Association of occult metastases in sentinel lymph nodes and bone marrow with survival among women with early-stage invasive breast cancer","volume":"306","author":"Giuliano","year":"2011","journal-title":"Jama."},{"key":"10.1016\/j.ygyno.2021.02.017_bb0125","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/S1470-2045(19)30395-X","article-title":"Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial","volume":"20","author":"de Boer","year":"2019","journal-title":"Lancet Oncol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825821001542?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825821001542?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T00:47:20Z","timestamp":1715820440000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825821001542"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S0090825821001542"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2021.02.017","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sentinel lymph node (SLN) isolated tumor cells (ITCs) in otherwise stage I\/II endometrioid endometrial cancer: To treat or not to treat?","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2021.02.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}